Securities code: 000835 securities abbreviation: * ST Changdong Announcement No.: 2021-197 Great Wall International Acg Co.Ltd(000835)
Suggestive announcement on the change of shareholders’ equity of the company exceeding 1%
Shanxi Zhenxing Biological Pharmaceutical Co., Ltd. guarantees that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
Great Wall International Acg Co.Ltd(000835) (hereinafter referred to as “Great Wall animation”, “company” or “listed company”) recently received the notification letter from Shanxi Zhenxing Biological Pharmaceutical Co., Ltd. (hereinafter referred to as “Zhenxing biological”). Zhenxing biological accepted the company’s shareholder Zhejiang Qingfeng primary culture Co., Ltd. (hereinafter referred to as “Qingfeng company”) on February 8, 2021 ）And the person acting in concert, Mr. Zhao ruiyong, have the right to vote. Recently, Qingfeng company had a share reduction, resulting in its equity changes accounting for more than 1% of the total shares of the company. The company hereby announces the relevant information as follows: I. Basic information of this equity change
1. Overview of this equity change
Equity held before this change equity held after this change
Nature of equity
Proportion of shares (shares) to total share capital proportion of shares (shares) to total share capital
Accepted by Qingfeng company 4235040212.96% 293504028.98%
Voting power entrustment
Accept Zhao ruiyong 24750000.76%
Voting power entrustment
Total 4482540213.72% 318254029.74%
2. Changes in equity this time
1. Basic information
Information disclosure obligor: Shanxi Zhenxing Biological Pharmaceutical Co., Ltd
Address: Ganjian village, Fancun Town, Hejin City, Yuncheng City, Shanxi Province
Change time of Equity: December 20, 2021
Stock abbreviation * ST Changdong stock code 000835
Change type
(more can be added □ less concerted action is available □
(optional)
Whether it is the largest shareholder or actual controller or not □
2. Changes in equity
Type of shares (A shares, B shares, etc.) decrease in equity number of shares (shares) decrease in equity (%)
A shares 1300000003.98
Total 1300000003.98
Centralized trading through stock exchange □
The way of equity change this time (mostly through block trading in stock exchanges □
(optional) others (passive reduction of voting rights entrusting party’s shares)
Self owned funds □ bank loans □
The capital source of this share increase is loans from other financial institutions □ shareholder investment □
(multiple choices are allowed) others □ (please specify)
Not involving the source of funds □
3. Shares of listed companies owned by investors and persons acting in concert before and after the change
Shares held before this change shares held after this change
Nature of shares proportion to total share capital proportion to total share capital number of shares (shares) (%) number of shares (shares) (%)
The total number of shares held by the company is 4235040212.96293504028.98
Wind: 209600286.1479600282.43
Shares with unlimited conditions
Shares with limited sales conditions of the company 213903746.55213903746.55
Total shares held: 24750000.7624750000.76
Zhao Zhong:
Rui shares with unlimited sales conditions 00.0000 00
Brave
Shares with limited sales conditions 24750000.7624750000.76
Total shares held 4482540213.72318254029.74%
4. Implementation of commitments, plans, etc
Whether this change is performance yes □ no
Commitment, intention and plan made. If yes, please explain the specific situation of commitment, intention and plan and the implementation progress. Row
Is there any violation of the securities law and the listed company in this change
Acquisition management measures and other laws yes □ no
Administrative regulations, departmental rules, if yes, please explain the specific situation of violation, rectification plan and treatment measures. Provisions of normative documents and business rules of the exchange 5 Shares with restricted voting rights
In accordance with Article 60 of the securities law yes □ no
Whether the provisions of Article 3 exist. If so, please explain the proportion of the corresponding number of shares in the share capital of the existing listed company. Non voting shares 6 Further explanation on the increase of shares held by more than 30% shareholders (if applicable) whether the increase is in line with the acquisition of listed companies
Exemption from tender offer stipulated in the administrative measures yes □ no □
7. Commitment of shareholders and persons acting in concert not to reduce their shares of the company within the legal period Documents for future reference 1. Details of shareholding changes of China Securities Depository and Clearing Co., Ltd
2. Relevant written commitment documents □
3. Written opinions of lawyers □
4. Other documents required by SZSE □
8. Other explanations: the company guarantees that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions. Shanxi Zhenxing Biological Pharmaceutical Co., Ltd. December 21, 2021
2、 Other relevant instructions and risk tips
1. In view of the fact that the shareholder’s share reduction and equity change exceed 1%, the company sent the inquiry letter on share reduction and equity change exceed 1% to Qingfeng company. In addition to the data provided by China Securities Depository and Clearing Co., Ltd. (hereinafter referred to as “zhongdeng company”), the company has not received legal documents, notices or other information from other parties on this matter. According to the query information of zhongdeng company, the company preliminarily determines that Qingfeng company’s reduction is a passive reduction, and does not rule out the possibility of continued reduction.
2. The company will continue to pay attention to the follow-up changes of the company’s shares held by Qingfeng company and its concerted actor Mr. Zhao ruiyong, earnestly perform the obligation of information disclosure in strict accordance with the provisions and requirements of relevant laws and regulations, and do a good job of information disclosure in a timely manner.
3. The information disclosure media designated by the company are cninfo.com and China Securities Journal. All information about the company shall be subject to the announcement published by the company in the above designated media. Please pay attention to the company’s announcement and pay attention to investment risks.
3、 Documents for future reference
1. Notification letter of Shanxi Zhenxing Biological Pharmaceutical Co., Ltd;
2. Shanxi Zhenxing biopharmaceutical Co., Ltd. announcement on changes in equity exceeding 1%.
It is hereby announced.
Great Wall International Acg Co.Ltd(000835) board of directors December 22, 2021
